Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study - Wikidata - wikimedia - TriplyDB

Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study

Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study

http://www.wikidata.org/entity/Q56428435

about

Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults Combating antimicrobial resistance: policy recommendations to save lives Procalcitonin-guided antibiotic therapy for septic patients in the surgical intensive care unit Meta-analysis and systematic review of procalcitonin-guided therapy in respiratory tract infections Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock--a systematic review and meta-analysis Using Procalcitonin to Guide Antibiotic Therapy.Biomarker-guided antibiotic therapy-strengths and limitations Procalcitonin biomarker kinetics fails to predict treatment response in perioperative abdominal infection with septic shock Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit.Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future.Procalcitonin to guide duration of antimicrobial therapy in intensive care units: a systematic review.Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis.New approaches to sepsis: molecular diagnostics and biomarkers.Empiric antibiotic, mechanical ventilation, and central venous catheter duration as potential factors mediating the effect of a checklist prompting intervention on mortality: an exploratory analysis Emerging and resistant infections Interventions to improve antibiotic prescribing practices for hospital inpatients.Procalcitonin levels associate with severity of Clostridium difficile infection Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic dur Diagnostic use of serum procalcitonin levels in pulmonary aspiration syndromes.Procalcitonin guided antibiotic therapy of acute exacerbations of asthma: a randomized controlled trial.Antibiotic stewardship programmes in intensive care units: Why, how, and where are they leading us.Design of clinical trials of antibacterial agents for community-acquired bacterial pneumonia How to treat VAP due to MDR pathogens in ICU patients.The use of a standardized PCT-algorithm reduces costs in intensive care in septic patients - a DRG-based simulation model.Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia.From starting mechanical ventilation to ventilator-associated pneumonia, choosing the right moment to start antibiotic treatment.Role of biomarkers in the management of antibiotic therapy: an expert panel review: I - currently available biomarkers for clinical use in acute infections Role of biomarkers in the management of antibiotic therapy: an expert panel review II: clinical use of biomarkers for initiation or discontinuation of antibiotic therapy A clinical trial comparing physician prompting with an unprompted automated electronic checklist to reduce empirical antibiotic utilization.Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.Procalcitonin for guidance of antibiotic therapy.Year in review 2009: Critical Care--infection.Diagnostic and prognostic biomarkers of sepsis in critical care.Strategies for reduction in duration of antibiotic use in hospitalized patients.The role of procalcitonin in respiratory infections.Biomarkers in community-acquired pneumonia.

P2860

Q24187768-12976B74-7E14-4CAB-96A9-2D3E77BFA764 Q24200676-435EBE8C-D629-487B-A6C3-627BC2193F5B Q24236108-739C6174-631F-4DD5-A21B-84216A02A6F9 Q24632857-DB02D656-A913-402E-9893-9BB5C1FCF223 Q26798459-B553EE64-025B-4DC4-B4CF-36CA44DC38FA Q27023057-B0C3C619-0760-4270-90D0-BBFD0FC821AA Q27028085-F7D9A9EE-3642-436C-8BBB-F9A1F3FC4533 Q33629591-035C8248-AABB-49E8-8167-16535C87E9BF Q33747590-902714D0-3BC7-41F4-B0CD-CA52875A2F9F Q33750023-C4DA3B90-B6F6-404D-BFB4-16A803D83BDB Q34003193-F90370D5-91D5-4302-A714-C832A659B3E4 Q34026963-206B744F-B6C3-48B4-9FC1-9C9BDA304CCC Q34027944-9693B4CB-6FEB-45D1-B822-B24DDA6D3264 Q34264291-15CC7832-C132-4DA1-A431-C80582CF652D Q34303687-00630822-3D85-4611-9BE8-071CB2B181B1 Q34337138-E3435276-0306-4549-9E33-9820AC1BA404 Q34357419-E45AE569-6F80-4C09-A27D-18430505FE37 Q34550823-2199FC16-B064-496E-8024-C404DD1D6EF4 Q34625689-14062DA9-0448-4E78-B911-6E2FFC75D9B3 Q34645044-0F77A8A3-AC6F-4BAC-B2BB-3858C9F48B7D Q34670419-CFA937B8-BA4B-4643-BC6A-D303755219D5 Q35007561-C4D5DB64-36D5-4BCD-88BD-579275FDBD57 Q35068408-4E6DD580-40E2-4F1A-A58D-6F95B891B0C8 Q35080067-00CD0092-16E4-4356-8360-0CAF8E4385A2 Q35215307-13DD1AB2-9C81-46A3-AB7E-5C1A55FB5A7D Q35457068-8AE9E947-372F-480C-BD38-61D8E4125538 Q35958759-6A667C41-3A79-4114-ACCB-A22C8A6348C9 Q36078359-B500D041-0523-478C-99C3-FA9C9540A20C Q36902744-A33A4B38-EA36-4823-B1F0-4E43C9FD0212 Q36965674-8AB01D70-21E0-48CF-830F-3E8B6EC7A2AB Q37004095-33DA7E1E-D405-4E1C-A8F8-F45FD8B38CA1 Q37028474-F589DF4F-810D-46DF-81A1-0EA51BB7E9B3 Q37266077-A69F3DE7-2A14-4323-B715-CB8A0A48FC60 Q37602669-C883E26B-54FC-41A1-80BB-7346634B35B3 Q37747406-5090AA0F-AFD2-4BEE-BA08-92F00CF2D593 Q37814492-CABCF886-7FBA-4B86-829C-536BFFFB1597 Q37852470-7D4454AB-E0C5-443D-9158-6AB62E02D679 Q37867329-7A5F30AB-8474-4230-9525-3CD5D382E3A5 Q37989831-394DC111-FEBD-4894-84C5-EDA824AC9A5C Q37997820-9DA57BB8-8FB4-464A-9EBA-D0597359E49A

P2860

Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study

http://www.wikidata.org/entity/Q56428435

description

im September 2009 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2009

@uk

name

Procalcitonin for reduced anti ...... pneumonia: a randomised study

@en

Procalcitonin for reduced anti ...... pneumonia: a randomised study

@nl

type

label

Procalcitonin for reduced anti ...... pneumonia: a randomised study

@en

Procalcitonin for reduced anti ...... pneumonia: a randomised study

@nl

prefLabel

Procalcitonin for reduced anti ...... pneumonia: a randomised study

@en

Procalcitonin for reduced anti ...... pneumonia: a randomised study

@nl

P1433

Q56428435-7D45DDB1-916E-4C85-ACBE-EDA30F54DC32

P1476

Q56428435-0FEFD044-BB2F-4AA2-A7C9-A1515B8DB844

P2093

Q56428435-189283C3-973E-4D27-87E9-FE494240D4FF

Q56428435-1A2E254E-34C4-4C0C-BA14-2ACC9129901E

Q56428435-1C82F203-6DE1-4159-8104-FEE9EC1234ED

Q56428435-4A47C3FA-7EAA-4B2A-AAA7-A6872CCF6792

Q56428435-A7EFF33A-584E-4B43-B200-484272D1FD45

Q56428435-A8BE3D94-AE95-4478-83B8-EE11E7B67787

Q56428435-B61E274B-6C69-4774-8601-89EB3656F0C0

Q56428435-BF2F9CCF-8BFF-4F62-8BAA-203F1E397AE4

Q56428435-C725872E-D665-4584-A18D-939B41982798

Q56428435-CCC99EE3-2F5F-4B3C-B6AC-110EE3C06EEF

P304

Q56428435-5F43AF06-1040-4470-8D19-3E3BB9B38421

P31

Q56428435-2FC609E7-3978-4001-9044-3E4C2EE12659

P356

Q56428435-808E4559-9DA3-4BEE-BADA-BE6CDAEB02EF

P433

Q56428435-351DADEC-6071-4F5E-A880-32178B2D0A14

P478

Q56428435-26921606-7AFC-4B52-9B44-0DDAFEDD00D5

P577

Q56428435-A9DB6487-C16A-45A9-B07E-DE0056B12845

P5875

Q56428435-9CA6951A-C50B-4E47-A212-ABC6BDAE65E2

P698

Q56428435-972D0AA0-3BD8-431E-AC45-C08BE422FC5F

P921

Q56428435-279AAB6F-0F01-4EE5-9044-67913BB58614

Q56428435-DD63D2FB-3A14-4EC0-9AF8-1BEC4CB67D52

P356

09031936.00053209

P1433

European Respiratory Journal

P1476

Procalcitonin for reduced anti ...... pneumonia: a randomised study

@en

P2093

A. Azzola

http://www.w3.org/2001/XMLSchema#string

B. Mueller

http://www.w3.org/2001/XMLSchema#string

D. Stolz

http://www.w3.org/2001/XMLSchema#string

H. Pargger

http://www.w3.org/2001/XMLSchema#string

J. Rakic

http://www.w3.org/2001/XMLSchema#string

M. Siegemund

http://www.w3.org/2001/XMLSchema#string

M. Tamm

http://www.w3.org/2001/XMLSchema#string

N. Smyrnios

http://www.w3.org/2001/XMLSchema#string

N. Thakkar

http://www.w3.org/2001/XMLSchema#string

P. Eggimann

http://www.w3.org/2001/XMLSchema#string

P304

1364-1375

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1183/09031936.00053209

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26863525

http://www.w3.org/2001/XMLSchema#string

P698

19797133

http://www.w3.org/2001/XMLSchema#string

P921